Adiponectin in Patients With Metabolic Disorders

NCT07539584 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

130

Enrollment

OTHER_GOV

Sponsor class

Conditions

Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: SGLT2 inhibitor
DRUG: GLP-1 RA

Sponsor

Moscow Regional Research and Clinical Institute (MONIKI)

Collaborators

[object Object]
[object Object]